Printer Friendly

BIOPOOL COMPLETES FINANCING

 VENTURA, Calif., June 3 /PRNewswire/ -- Biopool International Inc. (NASDAQ: BIPL) today announced it has completed the private placement of 1.166 million shares of its unregistered common stock to International Capital Partners Inc. of Stamford, Conn., and VK Capital Co. of San Francisco. Van Kasper & Co. acted as the placement agent in the transaction.
 Total financing was approximately $2.2 million at a price of $1.875 per share. The proceeds of the financing will be used by Biopool to pay down existing debt, to purchase capital equipment and fund other corporate expenditures, to increase research and development and to promote marketing efforts.
 Founded in 1987, Biopool develops, manufactures and markets a full range of test kits to assess and diagnose disorders of blood coagulation, fibrinolysis, platelet function and the vascular system, as well as test kits to determine thrombotic risk factors. The company's products are sold to hospitals and clinical laboratories worldwide.
 -0- 6/3/93
 /CONTACT: Michael D. Bick, Ph.D., CEO, 805-654-0643, or Andrew L. Cerskus, Ph.D., president, 416-332-9419, both of Biopool International; or Roger S. Pondel of Pondel Parsons & Wilkinson, 310-207-9300, for Biopool International/
 (BIPL)


CO: Biopool International Inc. ST: California IN: MTC SU: FNC

JL-LS -- LA011 -- 4798 06/03/93 09:05 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 3, 1993
Words:209
Previous Article:COMPOUNDING TECHNOLOGY INC. CREATES NEW POSITIONS OF CHAIRMAN AND PRESIDENT
Next Article:GLENFED REACHES KEY AGREEMENTS TO RESTRUCTURE SECURITIES; ANTICIPATES EXTENTION OF JUNE 30 TARGET DATE TO RAISE CAPITAL
Topics:


Related Articles
BIOPOOL INTERNATIONAL INC. COMPLETES THE ACQUISITION OF MEDICAL DIAGNOSTIC TECHNOLOGIES INC.
BIOPOOL PRESENTS PAPER AT INTERNATIONAL FIBRINOLYSIS CONFERENCE
BIOPOOL REPORTS SECOND CONSECUTIVE PROFITABLE QUARTER
BIOPOOL RECEIVES TWO NEW PATENTS
BIOPOOL REPORTS RECORD YEAR-END RESULTS
BIOPOOL SIGNS LETTER OF INTENT FOR $2 MILLION FINANCING
BIOPOOL REPORTS FIRST QUARTER RESULTS AND FIFTH CONSECUTIVE PROFITABLE QUARTER
BICK ELECTED CHAIRMAN OF BOARD, KAUFMAN ELECTED BOARD MEMBER OF BIOPOOL
BIOPOOL POSTS SECOND QUARTER OPERATING RESULTS
BIOPOOL REPORTS THIRD QUARTER RESULTS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters